News Sign up to receive news alerts. Your Email* Δ YOUR EMAIL HAVN LIFE SCIENCES Inc. PROVIDES BI-WEEKLY MCTO STATUS UPDATE September 15, 2023 HAVN ANNOUNCES ANTICIPATED LATE FILING OF FINANCIAL STATEMENTS AND APPLICATION FOR MANAGEMENT CEASE TRADE ORDER August 30, 2023 HAVN LIFE ANNOUNCES CHANGE OF AUDITOR July 26, 2023 HAVN LIFE PROVIDES CORPORATE UPDATE January 10, 2023 HAVN Life Announces Retail Listing With Loblaws Company Ltd. October 27, 2022 HAVN LIFE ANNOUNCES BOARD AND MANAGEMENT CHANGES October 17, 2022 HAVN LIFE ANNOUNCES DEPARTURE OF TIM LAIDLER AS DIRECTOR September 29, 2022 HAVN Life Provides Corporate Update September 20, 2022 HAVN Life Announces the close of the first tranche of its previously announced Financing Commitment by Alpha Blue Ocean and Warrant Amendments and the Issuance of Shares for Debt August 22, 2022 HAVN Life Announces a 30:1 Consolidation of its Common Shares August 2, 2022 HAVN Life To Begin Supplying its Naturally Derived Psilocybin Products For Use in World’s Largest Medical Psilocybin and Real World Data Project July 28, 2022 HAVN Life Announces Financing Commitment of CAD$9,000,000 through the issuance of Convertible Debentures and Warrants July 21, 2022
